Page last updated: 2024-12-06

thiophenoxyacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Thiophenoxyacetic acid (TPA) is a synthetic organic compound with a sulfur-containing aromatic ring. It is typically synthesized through a reaction between thiophenol and chloroacetic acid in the presence of a base. TPA exhibits various biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. It has been studied for its potential therapeutic applications in treating various diseases, such as inflammatory bowel disease, skin infections, and cancer. TPA's unique chemical structure and its ability to interact with biological targets make it a promising candidate for further investigation in medicinal chemistry.'

thiophenoxyacetic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID59541
CHEMBL ID459548
SCHEMBL ID74365
MeSH IDM0046994

Synonyms (61)

Synonym
AN-651/40187870
(phenylsulfanyl)acetic acid
TIMTEC1_005810
phenylmercaptoacetic acid
phenylthioglycolic acid
nsc9582
(phenylthio)acetic acid
nsc-9582
acetic acid, (phenylthio)-
103-04-8
carboxymethyl phenyl sulfide
2-phenylsulfanylacetic acid
(phenylmercapto) acetic acid
(phenylthio)acetic acid, 96%
STK288062
NCGC00173488-01
HMS1550I02
s-phenylthioglycolic acid
(phenylmercapto)acetic acid
thiophenoxyacetic acid
P0753
s-phenylmercaptoacetic acid
CHEMBL459548 ,
AKOS000120737
A800668
BBL000591
2-(phenylsulfanyl)acetic acid
nsc 9582
unii-m12342ppgs
m12342ppgs ,
phenyl thioacetic acid
einecs 203-073-9
ai3-26091
FT-0605012
2-(phenylthio)acetic acid
F0908-3954
.alpha.-carboxythioanisole
phenylthioglycolic acid [inci]
(s-phenylmercapto)acetic acid
acetic acid, 2-(phenylthio)-
SCHEMBL74365
phenylsulfanyl-acetic acid
(phenylthio) acetic acid
J-620013
TS-02283
.alpha.-(phenylthio)acetic acid
(phenylsulfanyl)acetic acid #
W-108858
(phenylthio)aceticacid
DTXSID4074431
sr-01000529120
SR-01000529120-1
mfcd00004355
BCP21455
EN300-20932
D70930
Q27283331
bdbm50587795
CS-W016037
SY007604
Z104484982
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Free fatty acid receptor 1Homo sapiens (human)EC50 (µMol)0.00600.00030.73698.8000AID1846358
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 1Homo sapiens (human)
insulin secretionFree fatty acid receptor 1Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 1Homo sapiens (human)
glucose homeostasisFree fatty acid receptor 1Homo sapiens (human)
positive regulation of calcium ion transportFree fatty acid receptor 1Homo sapiens (human)
response to fatty acidFree fatty acid receptor 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of insulin secretionFree fatty acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityFree fatty acid receptor 1Homo sapiens (human)
lipid bindingFree fatty acid receptor 1Homo sapiens (human)
bioactive lipid receptor activityFree fatty acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID388280Inhibition of Blattella germanica peptidylamidoglycolate lyase assessed as ascorbate-independent dealkylation of alpha-hydroxy-hipurate2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID388281Inhibition of Blattella germanica peptidyl alpha-hydroxylating monooxygenase assessed as inhibition of N-dansyl-Tyr-Val-Gly amidation by RP-HPLC2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID1846358Agonist activity at FFAR1 (unknown origin) expressed in CHO cells by FLIPR calcium assay2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicity.
AID388275Inhibition of rat recombinant peptidylglycine alpha-amidating monooxygenase assessed as inhibition of N-dansyl-Tyr-Val-Gly amidation2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's3 (20.00)18.2507
2000's6 (40.00)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.16 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]